ACC
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma (NCT01898715) | Millendo Therapeutics, Inc. | 2013-08-13 |
| A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (NCT01678105) | Ontario Clinical Oncology Group (OCOG) | 2012-11-01 |
| A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients (NCT01262235) | Arbutus Biopharma Corporation | 2010-12-01 |
Track ACC automatically
Every clearance here is in the API, with alerts when new ones post.